About the CIRB

OUR MISSION

The NCI Central Institutional Review Board is dedicated to protecting the rights and welfare of participants in cancer clinical trials. Institutions across the country rely on our national experts to ensure that clinical trials are reviewed efficiently and with the highest ethical and quality standards. We play a critical role in helping the National Cancer Institute accelerate scientific discovery and improve cancer prevention, treatment and care.

AT A GLANCE

Created in 2001Supports all 50 states and Puerto Rico
Serves over 1,800 institutions Has more than 450 studies to institutions